文献速递免疫规划传染病防控与疫情报告

不同环境条件下分泌的霍乱弧菌外膜囊泡的免疫原性

Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions.
PubMed 文献 · Vaccine · 2017-11-27

世界卫生组织(WHO)建议在霍乱流行或暴发风险地区使用现有霍乱疫苗进行免疫。本研究在小鼠霍乱实验模型中,评价了用不同方法制备、在两种不同生长条件下获得的外膜囊泡(OMVs)负载于壳聚糖-三聚磷酸(TPP)纳米颗粒并包覆肠溶聚合物Eudragit后疫苗候选物的保护效果。

要点

  • WHO建议在霍乱流行或暴发风险地区使用现有霍乱疫苗进行免疫。
  • 小鼠实验中,黏膜途径接种纳米颗粒包裹的OMVs可完全抵抗霍乱弧菌感染。

核心结论

  • 通过黏膜途径接种新疫苗时可完全保护小鼠免受霍乱弧菌感染。
  • 经腹腔途径接种时,未聚合的OMVs提高了对霍乱弧菌的保护作用。

研究设计与样本

  • 研究在小鼠霍乱实验模型中评价不同方法制备、两种不同生长条件下获得的外膜囊泡(OMVs)负载于壳聚糖-三聚磷酸(TPP)纳米颗粒并包覆Eudragit后疫苗候选物的保护效果。
  • OMVs经离子凝胶法包裹于壳聚糖-TPP纳米颗粒中,并包覆肠溶聚合物Eudragit。
  • 负载OMVs的纳米颗粒(NP-OMVs)均匀呈球形,粒径为417nm。
  • BALB/c小鼠(雄性,20-24g)经腹腔(10µg)或口服(50µg)途径接种游离或包裹的OMVs。
  • 首次给药后78天,小鼠血清被霍乱弧菌感染剂量(≥10^7 CFU)感染。

主要发现

  • 负载OMVs的纳米颗粒(NP-OMVs)均匀呈球形,粒径为417nm。
  • 新疫苗经黏膜途径接种时可完全保护小鼠免受霍乱弧菌感染。
  • 经腹腔途径接种时,未聚合的OMVs提高了对霍乱弧菌的保护作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cholera is caused by toxigenic Vibrio cholerae. It is a significant health problem and an important cause of mortality of children in developing countries. Annually, about 5-7 million people are being infected worldwide, leading to death of 100,000 to 120,000. Immunization using the currently available cholera vaccines has been recommended by World Health Organization (WHO) in areas where cholera is endemic or at risk of outbreaks. Gram-negative bacteria secrete outer membrane vesicles (OMVs) that play important roles in virulence and host-pathogen interaction. The content of protein and lipid in OMVs are affected by purification methods and bacterial growth condition. OMVs released from V. cholerae are an appropriate candidate for vaccine development. The protection conferred by a new vaccine candidate prepared using different methods and in two different growth conditions with nanoparticles in an experimental model of cholera in mice was investigated. OMVs were encapsulated in chitosan-tripolyphosphate (TPP) nanoparticles prepared by an ionic gelation method and coated with Eudragit as an enteric polymer. OMVs loaded into nanoparticles (NP-OMVs) were homogeneous and spherical in shape, with a size of 417nm. BALB/c mice (male, 20-24g) were immunized via intraperitoneal (10µg) or oral route (50µg) with free or encapsulated OMVs. Seventy-eight days after first administration, serum of mice was infected with infection dose of V. cholerae (≥107 CFU). The new vaccine was able to protect fully against infection when it was administered via mucosa. By intraperitoneal route, the unpolymerized OMVs increased the protection against these bacteria.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Adriani R, Mousavi Gargari SL, Nazarian S, et al. Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions. Vaccine. 2017. PMID: 29191736. doi:10.1016/j.vaccine.2017.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。